BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15150086)

  • 1. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.
    Xu Y; Sumter TF; Bhattacharya R; Tesfaye A; Fuchs EJ; Wood LJ; Huso DL; Resar LM
    Cancer Res; 2004 May; 64(10):3371-5. PubMed ID: 15150086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.
    Chia L; Wang B; Kim JH; Luo LZ; Shuai S; Herrera I; Chen SY; Li L; Xian L; Huso T; Heydarian M; Reddy K; Sung WJ; Ishiyama S; Guo G; Jaffee E; Zheng L; Cope LM; Gabrielson K; Wood L; Resar L
    J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36919699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line.
    Khajouee S; Baghbani E; Mohammadi A; Mansoori B; Shanehbandi D; Hajiasgharzadeh K; Baradaran B
    Adv Pharm Bull; 2022 Mar; 12(2):398-403. PubMed ID: 35620335
    [No Abstract]   [Full Text] [Related]  

  • 4. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
    Li L; Kim JH; Lu W; Williams DM; Kim J; Cope L; Rampal RK; Koche RP; Xian L; Luo LZ; Vasiljevic M; Matson DR; Zhao ZJ; Rogers O; Stubbs MC; Reddy K; Romero AR; Psaila B; Spivak JL; Moliterno AR; Resar LMS
    Blood; 2022 May; 139(18):2797-2815. PubMed ID: 35286385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of the high mobility group A proteins in hematological malignancies.
    De Martino M; Esposito F; Fusco A
    Hematol Oncol; 2022 Feb; 40(1):2-10. PubMed ID: 34637548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
    Pujals M; Resar L; Villanueva J
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 induces EZH2 overexpression in human B-cell lymphomas.
    De Martino M; Nicolau-Neto P; Ribeiro Pinto LF; Traverse-Glehen A; Bachy E; Gigantino V; De Cecio R; Bertoni F; Chieffi P; Fusco A; Esposito F
    Am J Cancer Res; 2021; 11(5):2174-2187. PubMed ID: 34094676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between HMGA and TP53 in cell cycle control along tumor progression.
    Meireles Da Costa N; Palumbo A; De Martino M; Fusco A; Ribeiro Pinto LF; Nasciutti LE
    Cell Mol Life Sci; 2021 Feb; 78(3):817-831. PubMed ID: 32920697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA Proteins in Hematological Malignancies.
    Minervini A; Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32503270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.
    De Martino M; De Biase D; Forzati F; Credendino SC; Palma G; Barbieri A; Arra C; Paciello O; Gaudio E; Ponzoni M; De Vita G; Chieffi P; Bertoni F; Fusco A; Esposito F
    Sci Rep; 2020 Apr; 10(1):7057. PubMed ID: 32341372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA Genes and Proteins in Development and Evolution.
    Vignali R; Marracci S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
    Resar L; Chia L; Xian L
    Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of high mobility group A proteins to the mammalian genome occurs as a function of AT-content.
    Colombo DF; Burger L; Baubec T; Schübeler D
    PLoS Genet; 2017 Dec; 13(12):e1007102. PubMed ID: 29267285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group A1 protein modulates autophagy in cancer cells.
    Conte A; Paladino S; Bianco G; Fasano D; Gerlini R; Tornincasa M; Renna M; Fusco A; Tramontano D; Pierantoni GM
    Cell Death Differ; 2017 Nov; 24(11):1948-1962. PubMed ID: 28777374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche.
    Xian L; Georgess D; Huso T; Cope L; Belton A; Chang YT; Kuang W; Gu Q; Zhang X; Senger S; Fasano A; Huso DL; Ewald AJ; Resar LMS
    Nat Commun; 2017 Apr; 8():15008. PubMed ID: 28452345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of HMGA proteins in cancer cell chemoresistance.
    D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
    J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
    Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
    Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review.
    Nguyen AH; Bhavsar SB; Riley EM; Caponetti GC; Agrawal DK
    Contemp Oncol (Pozn); 2016; 20(6):425-429. PubMed ID: 28239277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.